LC-MS/MS raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-06-01 and is reviewed periodically as new material appears.
Storage conditions for research-grade SR9009 generally involve a freezer at approximately minus twenty degrees Celsius, sometimes lower for long-term preservation. Containers should remain tightly closed and protected from light. Desiccants may be used to limit moisture uptake. Solutions are often stored in aliquots to avoid repeated warming and cooling. Stability data for the compound under various conditions are limited, so laboratories typically follow supplier recommendations and verify performance through periodic analytical checks rather than assuming indefinite stability.
Identity and purity testing for SR9009 commonly uses liquid chromatography coupled with tandem mass spectrometry. This method separates the compound from matrix components and detects it by mass-to-charge transitions, providing sensitive and specific confirmation. Nuclear magnetic resonance spectroscopy can support structural identification, while high-performance liquid chromatography with ultraviolet detection may estimate purity. Because online products labeled as SR9009 may contain other substances or no active compound at all, independent verification is important in research settings. Certificates of analysis are useful but not a substitute for in-house testing.
Laboratory samples of SR9009 are typically supplied as a white to off-white powder. The compound dissolves readily in organic solvents such as dimethyl sulfoxide and ethanol, while its solubility in water is low. Because of this solubility profile, researchers often prepare concentrated stock solutions in an organic solvent before diluting them into aqueous assay buffers. Light exposure, moisture, and repeated freeze-thaw cycles can degrade many small molecules, so handling procedures usually aim to minimize these factors. Purity is commonly checked before use.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Typical for research-grade material |
| Solubility | Soluble in DMSO and ethanol; low aqueous solubility | Organic stock solutions are common |
| Typical storage temperature | -20 °C or lower | Protect from light and moisture |
| Common analytical method | LC-MS/MS | Used for detection and confirmation |
| Common synonyms | SR9009; Stenabolic | Stenabolic is an informal name |
In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.
Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.
SR9009 is a synthetic small molecule developed as a REV-ERB agonist. It binds to REV-ERBα and REV-ERBβ, nuclear receptors that help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, the compound alters lipid and glucose handling and influences skeletal muscle oxidative capacity. Its exact effects in humans remain largely uncharacterized because controlled clinical trials have not been reported. The molecule is frequently described in preclinical literature as a metabolic modulator.
Research interest in SR9009 grew from studies showing improved running endurance in mice after short treatment periods. Those experiments linked the compound to increased mitochondrial content and fatty acid oxidation in muscle, but the findings come from animal models and specific dosing schedules. Independent replication has been limited, and the pathways connecting REV-ERB activation to exercise performance are still being mapped. Whether similar responses occur in humans is an open question.
Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.
SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.
SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.
Quality control for research materials includes identity confirmation by nuclear magnetic resonance and purity assessment by high-performance liquid chromatography. Mass spectrometry provides molecular weight confirmation and can detect related impurities. Purchasers should request a certificate of analysis that lists lot-specific data. Online products advertised for human use often lack such documentation. Distinguishing legitimate research material from mislabeled or contaminated samples is a recurring challenge in independent testing, and independent laboratories may use orthogonal methods to verify identity.
Detection of SR9009 in biological samples usually relies on liquid chromatography coupled to tandem mass spectrometry. This approach separates the compound from matrix components and identifies it by mass transitions. Because SR9009 can undergo metabolism, laboratories often look for both parent drug and specific metabolites. Sample preparation may involve protein precipitation or solid-phase extraction. Method validation examines sensitivity, carryover, and interference from related substances, and reference standards are required for accurate calibration.
Storage recommendations for SR9009 reference material typically specify a freezer at -20 °C or lower, with protection from moisture and light. Repeated freeze-thaw cycles can degrade small molecules and introduce variability. Stock solutions in dimethyl sulfoxide are often aliquoted to avoid repeated handling. Stability studies may examine degradation under heat, humidity, and light exposure. The compound's thiophene and nitro groups can participate in reactions that alter analytical signals over time, so such changes affect quantitative results.
Their study analysed five loci from 149 species. The phylogeny identified monophyletic versus polyphyletic genera. For instance, Bacidia in its broad traditional sense was polyphyletic, as was Toninia and a few others. Character mapping suggested an ancestor with a filamentous thallus in moist shade and multi-septate spores. Traits like the phyllopsoroid growth form (tiny leaf-like squamules as in genus Phyllopsora) were found to have evolved repeatedly within the family. Guided by these results, the authors synonymized six genera, resurrected four, and described two new ones, publishing 49 new combinations. In total, they published 49 new combinations to assign species to the appropriate genus under the new scheme. The redefined family now comprises 39 genera grouped into five well-supported clades (sometimes informally called the Bacidia group, Ramalina group, named after representative genera). Aligning genera with clades improves identifications because traits now track evolutionary affinity. These large‑scale revisions exemplify the kind of evidence‑rich approach—multiple loci, morphology and broad sampling—that Nimis had earlier promoted as a prerequisite for accepting new genera. In both cases, an evidence-rich, collaborative approach (combining multiple DNA markers with morphology and broad sampling) led to a more natural and stable classification.
As well as being extracted from nuclear waste, radioisotopes can be produced deliberately with nuclear reactors, exploiting the high flux of neutrons present. These neutrons activate elements placed within the reactor. A typical product from a nuclear reactor is iridium-192, from activation of iridium targets. The elements that have a large propensity to take up neutrons in the reactor are said to have a high neutron cross-section, but even at low cross-sections this process is generally economical. Particle accelerators such as cyclotrons accelerate particles to bombard a target to produce radionuclides. Cyclotrons accelerate (most often) protons at a target to produce positron-emitting radionuclides, e.g. fluorine-18. Radionuclide generators, standard for many medical isotopes, contain a parent radionuclide that decays to produce a shorter-lived radioactive daughter. A typical example is the technetium-99m generator, which employs molybdenum-99 produced in a reactor.
Metformin, sold under the brand name Glucophage, among others, is the main first-line medication for the treatment of type 2 diabetes, particularly in people who are overweight. It is also used in the treatment of polyendocrine metabolic ovarian syndrome, and is sometimes used as an off-label adjunct to lessen the risk of metabolic syndrome in people who take antipsychotic medication. It has been shown to inhibit inflammation, and is not associated with weight gain. Metformin is taken by mouth. Metformin is generally well tolerated. Common adverse effects include diarrhea, nausea, and abdominal pain. It has a small risk of causing low blood sugar. High blood lactic acid level (acidosis) is a concern if the medication is used in overly large doses or prescribed to people with severe kidney problems. Metformin is a biguanide anti-hyperglycemic agent. It works by decreasing glucose production in the liver, increasing the insulin sensitivity of body tissues, and increasing GDF15 secretion, which reduces appetite and caloric intake. Metformin was first described in the scientific literature in 1922 by Emil Werner and James Bell. French physician Jean Sterne began the study in humans in the 1950s. It was introduced as a medication in France in 1957. It is on the World Health Organization's List of Essential Medicines. It is available as a generic medication. In 2023, it was the second most commonly prescribed medication in the United States, with more than 85 million prescriptions. In Australia, it was one of the top 10 most prescribed medications between 2017 and 2023.
==== Surface gene variants among hepatitis B virus carriers ==== DNA sequences of HBsAg were obtained from 180 patients, in which 51 were chronic HBV carrier and 129 newly diagnosed patients, and compared with consensus sequences built with 168 HBV sequences imported from GenBank. Literature review and BLOSUM scores were used to define potentially altered antigenicity.
) drive capillary action in soil. A practical application of capillary action is the capillary action siphon. Instead of utilizing a hollow tube (as in most siphons), this device consists of a length of cord made of a fibrous material (cotton cord or string works well). After saturating the cord with water, one (weighted) end is placed in a reservoir full of water, and the other end placed in a receiving vessel. The reservoir must be higher than the receiving vessel. A related but simplified capillary siphon only consists of two hook-shaped stainless-steel rods, whose surface is hydrophilic, allowing water to wet the narrow grooves between them. Due to capillary action and gravity, water will slowly transfer from the reservoir to the receiving vessel. This simple device can be used to water houseplants when nobody is home. This property is also made use of in the lubrication of steam locomotives: wicks of worsted wool are used to draw oil from reservoirs into delivery pipes leading to the bearings.
Sources: en.wikipedia.org
Dy2O3 + 6 HClO4 → 2 Dy(ClO4)3 + 3 H2O Solutions used in modern spectroscopic work have been prepared directly from Dy2O3 and concentrated perchloric acid. Dysprosium perchlorate hexahydrate has also been obtained by dissolving Dy2O3 in 50–60% perchloric acid, followed by removal of excess water under reduced pressure or by freeze-drying. Anhydrous Dy(ClO4)3 can be obtained by controlled dehydration of hydrated dysprosium perchlorate.
=== InPen === The InPen is a reusable, bluetooth-enabled insulin pen, manufactured by Medtronic, that can connect to Dexcom CGM systems. The InPen can connect to the G6 and G7 through the InPen app, the Apple iPhone's Heath app, and on the Apple Watch.
=== Zinc toxicity === Increased zinc consumption is another cause of copper deficiency. Zinc is often used for the prevention or treatment of common colds and sinusitis (inflammation of sinuses due to an infection), ulcers, sickle cell disease, celiac disease, memory impairment, and acne. Zinc is found in many common vitamin supplements and is also found in denture creams. Recently, several cases of copper deficiency myeloneuropathy were found to be caused by prolonged use of denture creams containing high quantities of zinc. Metallic zinc is the core of all United States currency coins, including copper-coated pennies. People who ingest many coins will have elevated zinc levels, leading to zinc-toxicity-induced copper deficiency and the associated neurological symptoms. This was the case for a 57-year-old woman diagnosed with schizophrenia. The woman consumed over 600 coins and started to show neurological symptoms such as unsteady gait and mild ataxia.
== See also == Outline of the Yemeni crisis, revolution, and civil war (2011–present) South Yemen insurgency COVID-19 pandemic in Yemen Yemen cholera outbreak Health in Yemen Famine in Yemen (2016-present)
Sources: en.wikipedia.org
=== Alprostadil === Alprostadil is used for two main purposes: the treatment of newborns with congenital heart defects and in treatment of erectile dysfunction. Some babies are born with heart defects which compromise blood flow to the body. In some defects, including tetralogy of Fallot, aortic valvular atresia, and Eisenmenger pulmonary hypertension, alprostadil is given intravenously by a nurse until surgery can be performed to repair the defect. The medication maintains a patent ductus arteriosus. The ductus arteriosus is a shortcut between the aorta and pulmonary artery, two large vessels branching off the heart. This shortcut allows the fetus to maintain blood flow before birth. However, it closes shortly after birth when the newborn can breathe oxygen. In babies with certain congenital defects, however, it's essential to keep the ductus arteriosus open to ensure at least some blood flow throughout the body. Side effects include decreased breathing or a lack of breathing at high doses. The medication can also cause hypotension, or low blood pressure. Alprostadil is also used for adults with erectile dysfunction. It is typically given when other medications are ineffective. The medication relaxes smooth muscle and allows the arteries in the corpus cavernosum of the penis to dilate. Blood then flows to the penis. This blood flow compresses the veins which drain blood from the penis, trapping the blood in the corpus cavernosum. This process leads to erection.
3,4-dehydro-thiomorpholine-3-carboxylate + NAD(P)H + H+ The two substrates of this enzyme are thiomorpholine 3-carboxylate and oxidised nicotinamide adenine dinucleotide (NAD+). Its products are 3,4-dehydro-thiomorpholine-3-carboxylate, reduced NADH, and a proton. Nicotinamide adenine dinucleotide phosphate can be used as an alternative cofactor. This enzyme belongs to the family of oxidoreductases, specifically those acting on the CH-NH group of donors with NAD+ or NADP+ as acceptor. The systematic name of this enzyme class is thiomorpholine-3-carboxylate:NAD(P)+ 5,6-oxidoreductase. Other names in common use include ketimine reductase, and ketimine-reducing enzyme. CRYM, a taxon-specific crystallin protein that also binds thyroid hormones has thiomorpholine-carboxylate dehydrogenase activity.
He expanded the Danevirke, assembled a fleet, mustered an army, and launched attacks on the Obotrites and later Frankish Frisia. But he was slain, either by one of his huscarls or possibly his own illegitimate son, on the Frisian campaign. The new Danish king, Hemming, Gudfred's nephew, initiated peace talks, which resulted in the Treaty of Heiligen in 810. The treaty established the Danish border at the Eider River. Charlemagne retained Saxony, including Holstein, and established the Limes Saxoniae as a border with the Obotrites. This agreement established firm boundaries between the Franks, Obotrites, and Danes, securing peace in the region.
Sources: en.wikipedia.org
Research-grade SR9009 is typically stored frozen at about minus twenty degrees Celsius, protected from light and moisture. Stock solutions are often kept in aliquots to avoid repeated freeze-thaw cycles. Specific storage conditions should follow the supplier's documentation.
Liquid chromatography with tandem mass spectrometry is widely used to detect and confirm SR9009 in laboratory samples. The technique offers high sensitivity and can distinguish the target compound from related substances. Nuclear magnetic resonance and ultraviolet detection may support identity and purity checks.
Online products labeled as SR9009 may vary in identity, purity, and actual content. Independent testing helps confirm that a sample matches its label and does not contain unexpected contaminants. This is important for reproducible research and for interpreting experimental results.
It is a synthetic compound studied as an agonist of REV-ERB nuclear receptors. It is not an approved medicine and has mainly been examined in laboratory and animal research.